FLUCONAZOLE TABLET

国家: 加拿大

语言: 英文

来源: Health Canada

有效成分:

FLUCONAZOLE

可用日期:

SORRES PHARMA INC

ATC代码:

J02AC01

INN（国际名称）:

FLUCONAZOLE

剂量:

100MG

药物剂型:

TABLET

组成:

FLUCONAZOLE 100MG

给药途径:

ORAL

每包单位数:

50/100

处方类型:

Prescription

治疗领域:

AZOLES

產品總結:

Active ingredient group (AIG) number: 0122529002; AHFS:

授权状态:

CANCELLED POST MARKET

授权日期:

2014-06-20

产品特点

PRODUCT MONOGRAPH
PR
FLUCONAZOLE
(Fluconazole)
Tablets 50 &100 mg
ANTIFUNGAL AGENT
SORRES PHARMA INC.
DATE OF PREPARATION:
6111 Royalmount Ave., Suite 100
June 16, 2010
Montreal, Quebec
H4P 2T4
CONTROL NO. 139393
_ _
_FLUCONAZOLE Product Monograph _
_Page 2 of 45_
TABLE OF CONTENTS
PART I: HEALTH PROFESSIONAL INFORMATION
......................................................... 3
SUMMARY
PRODUCT
INFORMATION.................................................................................
3
INDICATIONS
AND
CLINICAL
USE
......................................................................................
3
CONTRAINDICATIONS
...........................................................................................................
4
WARNINGS
AND
PRECAUTIONS
..........................................................................................
4
ADVERSE
REACTIONS............................................................................................................
7
DRUG
INTERACTIONS
..........................................................................................................
10
DOSAGE
AND
ADMINISTRATION
......................................................................................
14
OVERDOSAGE
........................................................................................................................
18
STORAGE
AND
STABILITY
..................................................................................................
19
DOSAGE
FORMS,
COMPOSITION
AND
PACKAGING ...................................................... 20
PART II: SCIENTIFIC INFORMATION
...............................................................................
21
PHARMACEUTICAL
INFORMATION..................................................................................
21
C
LINICAL
T
RIALS
........................................................................................................................
22
DETAILED
PHARMACOLOGY
......................................................................